Patient‐Derived iPSC‐Cardiomyocytes Reveal Subclinical Cardiomyocyte Dysfunction Associated With the CAV3 N‐Terminal Variant p.Ala46Thr
The CAV3 p.Ala46Thr mutation is previously associated with skeletal muscle damage only, with its myocardial impact and long‐term cardiac risks unclear. This study is aimed at investigating whether it induces subclinical myocardial damage at the cellular level and explore its mechanism using a patient‐specific iPSC‐CMs...